-
Archives
- February 2020
- August 2018
- July 2018
- June 2018
- July 2017
- May 2017
- January 2017
- October 2016
- June 2016
- March 2016
- January 2016
- November 2015
- August 2015
- July 2015
- June 2015
- May 2015
- June 2014
- May 2014
- April 2014
- December 2012
- September 2012
- July 2012
- May 2012
- April 2012
- February 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
-
Meta
Monthly Archives: January 2017
SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals
SNMMI has developed USP recommendations for compounded sterile radiopharmaceuticals. The recommendations aim to address certain common practices in the field of nuclear pharmacy that are not adequately defined by generally accepted practice standards. The society believes there is confusion in … Continue reading
Posted in PET Drugs
Leave a comment
FDA Issues Draft Guidances on Compounding and Repackaging Radiopharmaceuticals
On December 28th, the FDA issued two draft guidances that describe FDA’s proposed policies regarding the compounding and repackaging of radiopharmaceuticals for human use by state-licensed nuclear pharmacies or federal facilities, and outsourcing facilities. According to FDA, “the policies proposed … Continue reading
Posted in PET Drugs
Leave a comment